Matches in Nanopublications for { ?s ?p "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP384934.RAefpn2TRt3cU0ps0ZtvkH0Ws_dHmsBiSmuOdyXsNJZWU130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384934.RAefpn2TRt3cU0ps0ZtvkH0Ws_dHmsBiSmuOdyXsNJZWU130_provenance.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.
- NP614525.RAvAZ9R8-OvCdMjfu-eUdx3yRog7aS_rS4Gst5lNXjxbo130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614525.RAvAZ9R8-OvCdMjfu-eUdx3yRog7aS_rS4Gst5lNXjxbo130_provenance.